Clinical Trial Update: Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This document reports a Phase 1 trial evaluating celecoxib in patients with stage IIIB or stage IV non-small cell lung cancer. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED